Followers | 116 |
Posts | 11877 |
Boards Moderated | 1 |
Alias Born | 03/08/2004 |
Wednesday, August 24, 2016 6:41:23 AM
""Simlatus jumps in on March 9, 2016. Cleans up the Cap Table with massive issuances of 4.6B shares. Reverse Split's the stock down to 4.5M shares. I can only assume the 10Q ending 6-30-2016 will be less pages ? lol All of the noteholders have been tossed off the playing field, except Direct Capital. I hope management will lock-up those notes through an ELOC agreement with a less toxic player. ""
(Unaudited)
5. NOTES PAYABLE
Notes payable comprised as the following:
Special Situations
- 21,491
Direct Capital #1
47,121 70,671
Direct Capital #2
311,385 330,035
Direct Capital #3
- 360,000
Direct Capital #4
- 360,000
Direct Capital #5
- 240,000
Direct Capital #6
240,000 240,000
Direct Capital #7
140,000 240,000
Direct Capital #8
- 72
Direct Capital #11
11,000 11,000
Direct Capital #17
16,000 16,000
Direct Capital #18
- 23,000
Direct Capital #20
- 45,157
Direct Capital #21
- 80,000
Direct Capital #22
- 80,000
Direct Capital #23
- 80,000
Direct Capital #24
- 80,000
Direct Capital #25
- 80,000
Direct Capital #26
25,000 -
Direct Capital #27
36,000 -
Syndication Capital #1
- 5,000
Coventry Enterprises #2
- 2,114
LG Capital Funding
26,100 29,000
Blackbridge Capital #1
- 2,000
GW Holdings
42,500 46,500
ARC Capital Ltd
21,625 21,625
Microcap Equity
- 4,180
GHS Investment #1
- 12,748
Southridge Partners
- 15,655
Tide Pool
- 14,500
Anthony Super
24,000 23,020
V2IP LLC #1
- -
Rockwell Capital #3
- -
GHS Investment #2
6,146 -
Blackbridge Capital #2
80,400 -
V2IP LLC #2
10,000 -
Carl Ambrose
20,000 -
$ 1,057,277 $ 2,533,768
#1). You have money. Other people want it. All of it!
#2). You want easy money. So does everybody else. They'll get it, too....yours! (and all of it!)
#3). You tell yourself you're smart. You won't lose your money. Fact: Other people are smarter,
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM